drugset / Trial / NCT03332485

Safety and Efficacy Study of an Edible Colonoscopy Preparation

NCT03332485

Phase 2 Completed 60 enrolled Sebela Pharmaceuticals Development LLC
RandomizedParallel-groupDouble-blindOther

Summary

The purpose of this study is to evaluate the efficacy and safety of ECP (PEG 3350) Colon Prep Kit compared with MoviPrep split-dose as a colon-cleansing preparation for colonoscopy.

Timeline

Start
2017-11-20
Primary completion
2018-03-14
Completion
2018-03-14

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moviprep Other / unclassified
Subject polyethylene glycol Other / unclassified

Indications

No indication recorded.